Association of mortality risk with various definitions of intradialytic hypotension

Journal of the American Society of Nephrology

Volumn 26, Issue 3, 2015, Pages 724-734

  Flythe, Jennifer E ^a,b,c   Xue, Hui ^d   Lynch, Katherine E ^a,b   Curhan, Gary C ^a,b   Brunelli, Steven M ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e DAVITA CLINICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HAZARD RATIO; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; HYPOTENSION; INTRADIALYTIC HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK ASSESSMENT; UNITED STATES;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RISK ASSESSMENT; UNITED STATES;

EID: 84924023092     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014020222     Document Type: Article

References (27)

1. Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM: Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol 22: 1526-1533, 2011
2. Ronco C, Brendolan A, Milan M, Rodeghiero MP, Zanella M, La Greca G: Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney Int 58: 800-808, 2000
3. Shoji T, Tsubakihara Y, Fujii M, Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66: 1212-1220, 2004
4. Tisler A, Akócsi K, Borbás B, Fazakas L, Ferenczi S, Görögh S, Kulcsár I, Nagy L, Sámik J, Szegedi J, Tóth E, Wágner G, Kiss I: The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 18: 2601-2605, 2003
5. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F: Cardiac consequences of hypertension in hemodialysis patients. Semin Dial 17: 299-303, 2004
6. Orofino L, Marcén R, Quereda C, Villafruela JJ, Sabater J, Matesanz R, Pascual J, Ortuño J: Epidemiology of symptomatic hypotension in hemodialysis: Is cool dialysate beneficial for all patients? Am J Nephrol 10: 177-180, 1990
7. Workgroup KD; K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 [Suppl 3]: S1-S153, 2005
8. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
9. Dubin R, Owens C, Gasper W, Ganz P, Johansen K: Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension. Hemodial Int 15: 350-358, 2011
10. Zhou YL, Liu HL, Duan XF, Yao Y, Sun Y, Liu Q: Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension. Nephrol Dial Transplant 21: 3231-3237, 2006
11. Dheenan S, Henrich WL: Preventing dialysis hypotension: A comparison of usual protective maneuvers. Kidney Int 59: 1175-1181, 2001
12. Kyriazis J, Glotsos J, Bilirakis L, Smirnioudis N, Tripolitou M, Georgiakodis F, Grimani I: Dialysate calcium profiling during hemodialysis: Use and clinical implications. Kidney Int 61: 276-287, 2002
13. Oliver MJ, Edwards LJ, Churchill DN: Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol 12: 151-156, 2001
14. Imai E, Fujii M, Kohno Y, Kageyama H, Nakahara K, Hori M, Tsubakihara Y: Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int 69: 877-883, 2006
15. Munoz Mendoza J, Bayes LY, Sun S, Doss S, Schiller B: Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: A quality improvement study. Am J Kidney Dis 58: 956-963, 2011
16. PubMed: PubMed search. Available at: http://www.ncbi.nlm.nih.gov/pubmed. Accessed January 23, 2014
17. Palmer BF, Henrich WL: Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol 19: 8-11, 2008
18. Sulowicz W, Radziszewski A: Pathogenesis and treatment of dialysis hypotension. Kidney Int 70: S36-S39, 2006
19. Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, Konner K, Martin-Malo A, Pedrini L, Tattersall J, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 22[Suppl 2]: ii22-ii44, 2007
20. Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM: Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2: 960-967, 2007
21. Caplin B, Kumar S, Davenport A: Patients' perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant 26: 2656-2663, 2011
22. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: " U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54: 561-569, 1998
23. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G: Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 21: 502-525, 2000
24. Flythe JE, Curhan GC, Brunelli SM: Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int 83: 104-113, 20123
25. Flythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, Kunaparaju S, Brunelli SM: Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis 61: 966-974, 2013
26. Flythe JE, Curhan GC, Brunelli SM: Disentangling the ultrafiltration rate-mortality association: The respective roles of session length and weight gain. Clin J Am Soc Nephrol 8: 1151-1161, 2013
27. Chesterton LJ, Selby NM, Burton JO, McIntyre CW: Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 13: 189-196, 2009